Zostavax popularity leaves GPs' stocks dry

ELDERLY Australians have embraced the shingles vaccine to the point where there’s a shortage in three states, the distributor has confirmed.

At least 190,000 people have been vaccinated since 1 November when Zostavax (Seqirus, MSD) was rolled out for 70- to 79-year-olds under the National Immunisation Program.

GPs in Victoria, South Australia and Queensland have been experiencing shortages but new stock will be distributed this week, according to Dr Lorna Meldrum, Seqirus vice-president commercial operations, Asia Pacific.